The invention provides compounds of formula I [INSERT CHEMICAL STRUCTURE HERE] (I) and pharmaceutically acceptable salts thereof. The formula I thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
The invention provides compounds of formula II:
and pharmaceutically acceptable salts thereof. The formula II thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
[EN] THIAZOLYL COMPOUNDS USEFUL AS KINASE INHIBITORS<br/>[FR] UTILISATION DE COMPOSÉS THIAZOLYLE COMME INHIBITEURS DE KINASES
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2008079873A2
公开(公告)日:2008-07-03
[EN] The invention provides compounds of formula I [INSERT CHEMICAL STRUCTURE HERE] (I) and pharmaceutically acceptable salts thereof. The formula I thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease. [FR] Cette invention concerne des composés de formule I et leurs sels pharmaceutiquement acceptables. Les composés thiazolyle de formule I inhibent l'activité des tyrosine kinases, ce qui les rend utiles comme agents anticancéreux, ainsi que dans le traitement de la maladie d'Alzheimer.
Synthesis of 3-arylindole derivatives from nitroalkane precursors
作者:Chia-Yu Huang、Chun-Wei Kuo、Ashok Konala、Tang-Hao Yang、Lyu Lin、Yu-Wen Chen、Veerababurao Kavala、Ching-Fa Yao
DOI:10.1039/c6ra21144e
日期:——
3-Arylindole derivatives were synthesized by Cu(I) catalysed intramolecular Ullmann coupling of 2-bromoarylaminoalkanes. 2-Bromoarylaminoalkanes were synthesized from 2-bromoarylnitroalkanes, which in turn prepared through AlCl3-mediated Friedel–Crafts alkylation of bromo-substituted β-nitrostyrenes and arenes.